Quick answers
- What is Lotensin HCT?
- Lotensin HCT is a brand name of Benazepril hydrochloride and hydrochlorothiazide, a prescription medicine. The FDA NDC Directory lists 3 Lotensin HCT products in 3 strengths and forms.
- Who makes Lotensin HCT?
- Validus Pharms holds the FDA application for Lotensin HCT (NDA020033, approved May 19, 1992).
- Is there a generic or store brand of Lotensin HCT?
- Yes. The FDA NDC Directory lists 9 other products with the same active ingredients, strength and form as a Lotensin HCT product, 9 of them generic. Ask your pharmacist whether one is right for you.
- Has Lotensin HCT been recalled?
- No recall linked to Lotensin HCT products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Lotensin HCT is
Each Lotensin HCT product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Benazepril hydrochloride and hydrochlorothiazide · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| benazepril hydrochloride 10 mg · hydrochlorothiazide 12.5 mg tablet (oral) | Lotensin HCT | 2 products, 2 companies | DailyMed |
| benazepril hydrochloride 20 mg · hydrochlorothiazide 12.5 mg tablet (oral) | Lotensin HCT | 4 products, 4 companies | DailyMed |
| benazepril hydrochloride 20 mg · hydrochlorothiazide 25 mg tablet (oral) | Lotensin HCT | 3 products, 3 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Benazepril hydrochloride and hydrochlorothiazide →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA020033 | Validus Pharms | May 19, 1992 | 3 |
Companies that list Lotensin HCT
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Lotensin HCT products.
- Validus Pharmaceuticals LLC3 products
Recalls
No recall linked to Lotensin HCT products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.